Ekaterina Malievskaia, a key shareholder in COMPASS Pathways plc (NASDAQ:CMPS), a company specializing in pharmaceutical preparations, has sold a significant number of shares, according to recent filings. The transactions, which occurred on April 16 and 17, 2024, involved the sale of ordinary shares with a total value exceeding $597,000.
The sales were executed in multiple transactions, with share prices ranging from $8.5289 to $8.7841. On April 16, Malievskaia sold 23,880 shares at an average price of $8.5289 and another 23,881 shares indirectly through her spouse, at the same average price. The following day, she continued to sell, disposing of 10,850 shares at an average price of $8.7841, both directly and indirectly through her spouse.
These sales were automatically conducted under a pre-established trading plan known as Rule 10b5-1, which allows insiders to sell shares at predetermined times to avoid accusations of insider trading. The plan was adopted on August 23, 2023.
Following these transactions, Malievskaia's direct holdings have decreased, but she still retains a substantial number of shares in COMPASS Pathways. The filings also noted that the ordinary shares may be represented by American Depositary Shares, where each represents one ordinary share.
Investors and followers of COMPASS Pathways will likely keep a close eye on insider transactions such as these for hints about the company's performance and the confidence level of its key stakeholders.
InvestingPro Insights
COMPASS Pathways plc (NASDAQ:CMPS) has seen its fair share of market activity, with notable insider sales by Ekaterina Malievskaia. Investors seeking a deeper understanding of the company's financial health might consider the following metrics from InvestingPro:
- Market Cap (Adjusted): 575.44M USD, indicating the company's current market valuation.
- Price to Earnings (P/E) Ratio (Adjusted) for the last twelve months as of Q4 2023: -4.86, reflecting the company's earnings relative to its share price, with negative values indicating lack of profitability.
- Six Month Price Total Return as of the current date in 2024: 39.84%, showing a significant uptick in share price over a half-year period.
Moreover, two InvestingPro Tips that may be particularly relevant to investors following Malievskaia's share sales are:
- The company holds more cash than debt on its balance sheet, which could be a sign of financial stability.
- Analysts do not anticipate the company will be profitable this year, which could explain the insider's decision to sell shares.
It's also worth noting that COMPASS Pathways has not been profitable over the last twelve months, and its stock price movements have been quite volatile. For investors interested in a comprehensive analysis, there are 9 additional InvestingPro Tips available at InvestingPro. To access these tips and more in-depth data, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.